Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Swedish Orphan Biovitrum AG
Sponsor

Swedish Orphan Biovitrum AG

Messeplatz 10, 4058

About the sponsor

Swedish Orphan Biovitrum AG supports clinical research in macrophage activation syndrome across systemic juvenile idiopathic arthritis and adult-onset Still’s disease, with interest in severe hyperinflammation and immune dysregulation in both children and adults.

  • Systemic juvenile idiopathic arthritis
  • Adult-onset Still’s disease
  • Hyperinflammatory syndrome

Its research activity in this area also extends to pediatric and adult rheumatology, reflecting a focus on life-threatening inflammatory complications.

About Specializations

Swedish Orphan Biovitrum AG runs clinical trials in conditions such as Haemophagocytic lymphohistiocytosis, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Haemophagocytic lymphohistiocytosis

Not recruiting
InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Emapalumab
  • Sponsor:Swedish Orphan Biovitrum AG

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.